During the past decade, Sydney Retina Clinic and Day Surgery conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sydney Retina Clinic and Day Surgery" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Apellis Pharmaceuticals, Inc." with 3 trials sponsored, "Allergan" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "BioFirst Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sydney Retina Clinic and Day Surgery" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sydney Retina Clinic and Day Surgery" are "Geographic Atrophy" (4 trials), "Macular Degeneration" (3 trials), "Macular Edema" (3 trials), "Diabetic Macular Edema" (2 trials) and "Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Sydney Retina Clinic and Day Surgery" in a lesser frequency.

Most popular intervention types in "Sydney Retina Clinic and Day Surgery" are "Drug" (17 trials), "Other" (6 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (9 trials), "Faricimab" (6 trials), "Aflibercept" (4 trials), "Placebo" (2 trials) and "Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sydney Retina Clinic and Day Surgery" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Sydney Retina Clinic and Day Surgery". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sydney Retina Clinic and Day Surgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sydney Retina Clinic and Day Surgery, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".